An Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractPolyethylene oxide has been researched extensively as an alternative polymer to hydroxypropyl methylcellulose (HPMC) in controlled drug delivery due to its desirable swelling properties and its availability in a number of different viscosity grades. Previous studies on HPMC have pointed out the importance of particle size on drug release, but as of yet, no studies have investigated the effect of particle size of polyethylene oxide (polyox) on drug release. The present study explored the relationship between polymer level and particle size to sustain the drug release. Tablets produced contained theophylline as their active ingredient and consisted of different polyethylene oxide particle size fractions (20-45, 45-90, 90-180 and 180-425 μm). It was shown that matrices containing smaller particle sizes of polyox produced harder tablets than when larger polyox particles were used. The release studies showed that matrices consisting of large polyox particles showed a faster release rate than matrices made from smaller particles. Molecular weight (MW) of the polymer was a key determining step in attaining sustained release, with the high MW of polyox resulting in a delayed release profile. The results showed that the effect of particle size on drug release was more detrimental when a low concentration of polyox was used. This indicates that care must be taken when low levels of polyox with different particle size fractions are used. More robust formulations could be obtained when the concentration of polyox is high. Differential scanning calorimetry (DSC) traces showed that particle size had no major effect on the thermal behaviour of polyox particles.
CitationAn Investigation on the Effect of Polyethylene Oxide Concentration and Particle Size in Modulating Theophylline Release from Tablet Matrices. 2015: AAPS PharmSciTech
- Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.
- Authors: Shojaee S, Nokhodchi A, Maniruzzaman M
- Issue date: 2017 Feb
- Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
- Authors: Mohamed FA, Roberts M, Seton L, Ford JL, Levina M, Rajabi-Siahboomi AR
- Issue date: 2015 Apr
- Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
- Authors: Shojaee S, Kaialy W, Cumming KI, Nokhodchi A
- Issue date: 2016 Mar
- Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets.
- Authors: Mitchell SA, Balwinski KM
- Issue date: 2007 Sep
- Effect of solvent on retarding the release of diltiazem HCl from Polyox-based liquisolid tablets.
- Authors: Kaialy W, Bello H, Asare-Addo K, Nokhodchi A
- Issue date: 2016 Nov